Biochemistry, Genetics and Molecular Biology
Cancer Cell
97%
Mouse
88%
Focal Adhesion Kinase
77%
Kinase
71%
Protein
68%
Gene Expression
62%
Apoptosis
59%
Drive
58%
Autophagy
51%
Integrin
49%
Growth
48%
Phenotype
46%
Senescence
45%
Nested Gene
36%
Oncogene
36%
Survival
35%
Tumor Suppressor Protein
35%
Secretion (Process)
32%
Transcription
31%
Solubility
31%
Dynamics
30%
Tumor Progression
30%
Metabolic Pathway
29%
Cell Activity
29%
Cell Aging
28%
Tumor Immunity
28%
Phosphorylation
26%
Drug Efficacy
25%
Integrin-Linked Kinase
25%
Glutamine
25%
Energy Transfer
25%
Catenin
25%
Immunoglobulin Enhancer Binding Protein
25%
Polymerase
25%
Interleukin-6
25%
Ribonucleotide
25%
WT1
25%
Histone Deacetylase
25%
Clone
25%
Conformation
25%
Insulin-Like Growth Factor 1 Receptor
25%
ISG15
25%
Inhibitor of Apoptosis
25%
Fibronectin
25%
Cell Growth
25%
Drug Tolerance
25%
Chemical Genetics
25%
Inflammasome
25%
Trametinib
25%
Colon
25%
Medicine and Dentistry
Cells
88%
Therapeutic Procedure
88%
Breast Cancer
86%
Neoplasm
73%
Ovarian Cancer
56%
In Vitro
53%
Programmed Cell Death
41%
Tumor Progression
40%
Survival
35%
Drive
34%
Targeted Therapy
34%
Tumor Cell
33%
Secretion (Process)
32%
Receptor
32%
Gene Expression
30%
Protein Tyrosine Kinase
30%
Tumor Xenograft
29%
Cell Activity
29%
Poly ADP Ribose Polymerase
29%
Tumor Immunity
28%
Growth
27%
Protein
27%
Serositis
25%
Lung Metastasis
25%
Bone
25%
Somatomedin C Receptor
25%
Protein P53
25%
Angiosarcoma
25%
Ribonucleotide
25%
Carcinogenicity
25%
Growth Disorder
25%
Gonadorelin Receptor
25%
Agonist
25%
Hydroxysteroid Dehydrogenase
25%
Bone Cell
25%
Toll Like Receptor
25%
MEK Inhibitor
25%
Fibrosis
25%
Cancer Model
25%
Tumor Angiogenesis
25%
Trametinib
25%
Osteoplasty
25%
Osteolysis
25%
Immunoglobulin Enhancer Binding Protein
25%
Fibronectin
25%
Evaluation Study
25%
Metastatic Carcinoma
25%
Focal Adhesion Kinase
25%
Lesion
25%
Autophagy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Mouse
73%
Breast Cancer
60%
Ovary Cancer
56%
Tumor Growth
40%
Phosphotransferase
38%
Survival
35%
Apoptosis
31%
Malignant Neoplasm
30%
Protein
30%
Protein Tyrosine Kinase
30%
Cancer Growth
28%
Antitumor Activity
28%
Inflammation
25%
Squamous Cell Carcinoma
25%
Structure Activity Relationship
25%
Somatomedin C Receptor
25%
Fibrosis
25%
Estrogen Receptor
25%
Capecitabine
25%
Trametinib
25%
Pertuzumab
25%
Tolerability
25%
Mitogen Activated Protein Kinase Kinase Inhibitor
25%
Hydroxysteroid Dehydrogenase
25%
Non Small Cell Lung Cancer
25%
Pharmacokinetics
25%
Immunoglobulin Enhancer Binding Protein
25%
Trastuzumab
25%
Receptor
25%
Toll Like Receptor
25%
Growth Disorder
25%
Pyrazolopyrimidine
25%
Fluorouracil
19%
Phosphotransferase Inhibitor
18%
Diseases
17%
Somatomedin C
14%
Toll Like Receptor 2
14%
Drug
14%
Agonist
14%
Lapatinib
12%
Cancer Model
12%
Doxifluridine
12%
Lung Cancer
11%
Osteoclast Differentiation Factor
11%
Solid Malignant Neoplasm
10%
Glucocorticoid
9%
Enzyme
9%
Pancreas Adenocarcinoma
9%
IC50
9%